Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

Ascorbate attenuates blood flow abnormalities in low flow POTS

Discussion in 'Latest ME/CFS Research' started by ramakentesh, Jun 3, 2011.

  1. ramakentesh

    ramakentesh Senior Member

    Messages:
    529
    Likes:
    109
  2. taniaaust1

    taniaaust1 Senior Member

    Messages:
    11,961
    Likes:
    12,890
    Sth Australia
    Very interesting... as I do find that this does help me when I take large doses of it
     

See more popular forum discussions.

Share This Page